Attached files
file | filename |
---|---|
EX-10.46 - LOAN AGREEMENT AND NOTE PAYABLE DATED JANUARY 6, 2017 - Cell MedX Corp. | cmxc_ex1046.htm |
10-Q - QUARTERLY REPORT - Cell MedX Corp. | cmxc_10q.htm |
EX-32.1 - CERTIFICATION - Cell MedX Corp. | cmxc_ex321.htm |
EX-31.2 - CERTIFICATION - Cell MedX Corp. | cmxc_ex312.htm |
EX-31.1 - CERTIFICATION - Cell MedX Corp. | cmxc_ex311.htm |
EX-10.48 - LOAN AGREEMENT AND NOTE PAYABLE DATED FEBRUARY 27, 2017 - Cell MedX Corp. | cmxc_ex1048.htm |
EX-10.47 - LOAN AGREEMENT AND NOTE PAYABLE DATED FEBRUARY 7, 2017 - Cell MedX Corp. | cmxc_ex1047.htm |
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Cell MedX Corp. (the Company) on Form 10-Q for the period ending February 28, 2017, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: April 14, 2017
/s/Yanika Silina
Yanika Silina
Chief Financial Officer
(Principal Accounting Officer)